Acute myocardial infarction and cardiogenic shock: Should we unload the ventricle before percutaneous coronary

Behnam N Tehrani1, Mir B Basir2, Navin K Kapur3

  • 1Inova Heart and Vascular Institute, Falls Church, VA, United States of America.

Insights

Cardiogenic shock (CS) after acute myocardial infarction (AMI) is deadly. Early left ventricular (LV) unloading strategies can improve outcomes by stabilizing hemodynamics and restoring heart function.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Hemodynamics

Background:

  • Cardiogenic shock (CS) is a major cause of mortality post-acute myocardial infarction (AMI).
  • CS involves hemodynamic instability, potentially leading to multi-organ failure.
  • Left ventricular (LV) load is a key predictor of mortality after AMI.

Purpose of the Study:

  • To review the pathophysiology and current treatment limitations of CS.
  • To explore preclinical and translational evidence for LV unloading strategies.
  • To advocate for incorporating LV unloading into contemporary AMI and shock care.

Main Methods:

  • Review of existing literature on CS pathophysiology and treatment.
  • Analysis of data from registries and pilot studies like DTU-STEMI.
  • Examination of preclinical and clinical research on LV unloading.

Main Results:

  • Early reperfusion and coordinated care have not eliminated CS mortality.
  • LV unloading is a promising strategy supported by extensive research.
  • Standardized approaches using early hemodynamics and circulatory support are emerging.

Conclusions:

  • LV unloading is critical for stabilizing hemodynamics in CS.
  • Tailored circulatory support to unload the LV can improve AMI outcomes.
  • Integrating LV unloading into standard care pathways is essential for reducing CS morbidity and mortality.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
326
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
95
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
159
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
461
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
181